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Abstract 
Proper cell fate choice of neutrophil-macrophage progenitor is essential for adequate 
myeloid sub-populations during embryonic development and in adulthood. The network 
governing neutrophil-macrophage progenitor cell fate is composed of several key 
determinants such as myeloid master regulators CCAAT enhancer binding protein alpha 
(C/EBPα) and spleen focus forming virus proviral integration oncogene (PU.1). Nevertheless, 
more regulators remain to be identified and characterized. To ensure balanced commitment of 
neutrophil-macrophage progenitor toward each lineage, the interplay among these 
determinants is not only synergistic, but also antagonistic. Depletion of Interferon regulatory 
factor 2 binding protein 2b (Irf2bp2b), a well known negative transcription regulator, results in 
a bias in neutrophil-macrophage progenitor cell fate choice which favors macrophages at the 
expense of neutrophils during the zebrafish definitive myelopoiesis stage in deficient embryos. 
Mechanistic studies indicate that Interferon regulatory factor 2 binding protein 2b acts as a 
downstream target of CCAAT enhancer binding protein alpha, to repress spleen focus forming 
virus proviral integration oncogene expression, and that SUMOylation confers the repressive 
function of Interferon regulatory factor 2 binding protein 2b. Thus, Interferon regulatory factor 
2 binding protein 2b is a novel determinant in the cell fate choice of neutrophil-macrophage 
progenitor. 
 
Introduction 
Hematopoiesis is the process by which uncommitted hematopoietic stem cells (HSCs) 
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proliferate and differentiate into all mature blood cell types1. The stepwise development of 
multipotent HSCs undergoes sequential lineage potential limitations toward oligopotent and 
unipotent progenitor cells, eventually restrict their output2. The molecular network governing 
every stage of hematopoiesis involves the interplay between multiple lineage-specific 
transcription factors/cofactors and epigenetic modifiers3. Any tiny disturbance of these factors 
could bias the lineage-restricted cell fate toward an alternate fate4.  
Neutrophil-macrophage progenitors (NMPs) generate neutrophil macrophage lineage 
cells, mainly neutrophils, monocytes, and macrophages. The gene regulatory network (GRN) 
governing NMPs cell fate is composed of primary determinants C/EBPα and PU.1, along with 
secondary determinants Gfi and Egr/Nab5, 6. Neutrophil cell fate specification requires 
C/EBPα, whereas macrophage cell fate specification depends on PU.17, 8. The relative levels 
of C/EBPα and PU.1 determines NMP cell fate choice. Low C/EBPα:PU.1 shifts the balance 
toward macrophage differentiation, whereas a high ratio directs granulocyte differentiation6. 
To keep myeloid lineage fidelity, the interplay among the determinants is important not only in 
initiating the differentiation toward one lineage, but also in inhibiting that of the other lineage. 
Gfi1 and Egr/Nab, the downstream transcription factors of C/EBPα and PU.1, function as 
mutual-antagonistic repressors to inhibit lineage-specific genes in mice5, 9. It has also been 
reported that the suppression of irf8, a downstream gene of Pu.1, leads to a depletion of 
macrophages and an expansion of neutrophils during zebrafish primitive myelopoiesis10. Irf8 
knockout mice even develop a chronic myeloid leukemia-like disease11, 12. Mechanistically, 
IRF8 impedes the ability of C/EBPα to stimulate neutrophil differentiation by preventing its 
binding to chromatin12. In addition to the transcription factors involved in C/EBPα and PU.1 
network, Runx1 was shown to repress pu.1 in a Pu.1-Runx1 negative feedback loop and 
determine the macrophage versus neutrophil fate13. 
IRF2BP2 is a member of the IRF2BP family that was initially identified as an interferon 
regulatory factor 2 (IRF2)-dependent corepressor in inhibiting the expression of 
interferon-responsive genes14. The IRF2BP family is highly conserved during evolution, and is 
structurally characterized by an N-terminal zinc finger motif which mediates homo- or 
hetero-dimerization/multimerization between different IRF2BP2 family members, and a 
C-terminal ring finger motif that interacts with its partners15. IRF2BP2 is described as a 
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corepressor in most published works14, 16, 17. The significance of IRF2BP2 in hematopoiesis 
was first revealed by genetic studies in Irf2bp2-deficient mice. IRF2BP2 acts with its binding 
partner ETO2, and the NCOR1/SMRT corepressor complex, to participate in erythroid 
differentiation16. As a ubiquitously distributed nuclear protein, IRF2BP2 plays multiple roles 
in various types of hematopoietic cells. For example, IRF2BP2 exerts a repressive function on 
nuclear factor of activated T cells (NFAT) target genes, which is another partner of IRF2BP217. 
IRF2BP2 is also shown to restrain naive CD4 T cell activation by inhibiting proliferation and 
CD25 expression18. Moreover, Irf2bp2-deficient macrophages were inflammatory in mice19. 
In recent years, four acute promyelocytic leukemia (APL) patients carring a novel fusion 
IRF2BP2-RARα have been reported. Nevertheless, the potential role of IRF2BP2 in 
leukemogenesis is still unclear20-23. 
In this study, we provide in vivo evidence demonstrating that the deficiency of irf2bp2b 
triggers biased NMPs cell fate choice favoring macrophage development during zebrafish 
definitive myelopoiesis, which adds Irf2bp2b to the repertoire of factors regulating NMP cell 
fate decision. Mechanistic studies indicate that Irf2bp2b, which is under the control of C/ebpα, 
inhibits pu.1 expression. We further reveal that SUMOylation is indispensable for the 
transcriptional repression of Irf2bp2b.  
 
Methods 
Zebrafish maintenance and mutant generation 
Zebrafish were raised, bred, and staged according to standard protocols24. For crisp9 mediated 
irf2bp2b knockout zebrafish generation, guide RNA targeting exon1 of irf2bp2b was designed 
using an online tool ZiFiT Targeter software.  
 
Plasmid construction 
Zebrafish irf2bp2b gene and its serial mutants were cloned into PCS2+ vector. The upstream 
sequences of zebrafish pu.1and irf2bp2b genes were cloned into PGL3 promoter vector 
(Promega). Primers used were listed in Table1. 
 
Whole-mount in situ hybridization (WISH) 
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Digoxigenin-labeled RNA probes were transcribed with T7, T3 or SP6 polymerase (Ambion, 
Life Technologies, USA). WISH was performed as described previously25.  
 
Semiquantitative RT-PCR 
The RNA preparation, cDNA synthesis, and quantitative RT-PCR were performed as described 
(Supplemental Methods). 
 
Retroviral transduction 
The IRF2BP2 cDNA was inserted into pMSCV-neo vector. For retroviral transduction, plat-E 
cells were transiently transfected with retroviral vectors. 32Dcl3 Cells were transduced by 
spinoculation (1,300 g, 30℃, 90 min) in a retroviral supernatant supplemented with cytokines 
and 4μg/ml polybrene (Sigma). Transduced cells were selected by G418 treatment (800mg/ml, 
Sigma). 
 
Statistical analysis 
For comparison of two means, statistical significance was evaluated by unpaired Student's 
t-test. For multiple comparisons, one-way analysis of variance (ANOVA) followed by LSD 
post hoc test for multiple comparisons. Differences were considered significant at P<0.05. 
 
The animal protocol listed above has been reviewed and approved by the Animal Ethical and 
Welfare Committee, Rui-Jin Hospital, Shanghai Jiao Tong University School of Medicine, 
Shanghai, China. 
 
Results  
Deficiency of zebrafish irf2bp2b causes a reduction of the neutrophil population and a 
simultaneous expansion of the macrophage population in the definitive myelopoiesis 
stage 
The IRF2BP gene family includes three members –IRF2BP1, IRF2BP2 and IRF2BPL, 
which are highly conserved throughout evolution15. All the family members bear a nearly 
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identical N-terminal C4-type zinc finger motif and a C-terminal C3HC4-type ring finger motif, 
whereas the intermediate domain between the zinc finger and the ring finger motifs shows 
relatively low similarity at the protein level15. There are two paralog genes of irf2bp2 named 
irf2bp2a and irf2bp2b in zebrafish, whereas a unique IRF2BP2 gene exists in the human 
genome, which generates two isoforms also named IRF2BP2a and IRF2BP2b due to 
alternative splicing. Human IRF2BP2a has a sixteen amino acids long additional sequence in 
its intermediate domain compared with IRF2BP2b. Yet, this additional sequence in human 
IRF2BP2a is not conserved in zebrafish Irf2bp2a/2b (Figure S1). Phylogenetic analysis 
showed that the two paralogs and human IRF2BP2 arose from a common ancestor, suggesting 
that functional divergence occurred early in vertebrate evolution26.  
The zebrafish is an excellent model organism for the study of hematopoiesis27. Like 
mammalian hematopoiesis, zebrafish hematopoiesis is also composed of primitive and 
definitive waves which emerge sequentially in distinct anatomical sites.  
Human IRF2BP2 mRNA is distributed in dozens of tissues, and the most prominent 
expression is found in bone marrow (https://www.ncbi.nlm.nih.gov/gene/359948). Zebrafish 
irf2bp2b is also ubiquitously expressed in developing embryos. irf2bp2b transcript was 
detected in the GFP positive cells enriched from Tg(gata1:eGFP), Tg(pu.1:eGFP), 
Tg(mpx:eGFP), and Tg(mpeg1.1:eGFP) embryos (Figure S2). To evaluate the effects of 
irf2bp2b on hematopoietic differentiation and lineage commitment, a mutant line was 
generated using the CRISPR/Cas9 system targeting the first exon of irf2bp2b gene and 
introduced a 26nt deletion which resulted in a truncated protein by frameshifting (Figure 
1A-B). Moreover, the mutant irf2bp2b gene was cloned into an HA tagged expressing vector 
and transfected into HEK293T cells. As expected, a short protein was detected by western blot 
analysis. Meanwhile, immunofluorescence analysis showed that this Irf2bp2b mutant protein 
lost its nuclear localization due to loss of the NLS28 (Figure 1C-D). 
A series of hematopoietic related markers was detected by WISH analysis during the 
primitive hematopoiesis stage in irf2bp2b-defecient embryos. The primitive macrophages and 
neutrophils derived from the rostral blood island (RBI), as well as erythrocytes and neutrophils 
originating from intermediate cell mass (ICM) kept unchanged (Figure S3A-L, W).  
Definitive pluripotent HSCs arise from the ventral wall of the dorsal aorta (VDA), the 
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zebrafish equivalent of the aorta/gonad/mesonephros (AGM) of mammals, then migrate 
through the caudal hematopoietic tissue (CHT) to the thymus and kidney marrow. WISH 
analyses revealed that the expression of the hematopoietic stem/progenitor cell (HSPC) related 
markers runx1 and c-myb was relatively unchanged in irf2bp2b-defecient embryos (Figure 
S3M-R, X). In addition, the erythroid marker hbαe1 (Figure S3S-T), and the lymphoid marker 
rag1 (Figure S3U-V) were also unaffected.  
As for myelopoiesis, a significant decrease in multiple neutrophil markers including 
c/ebp1 (neutrophil progenitor marker)29, mpx/lyz (mature neutrophil marker)30 and a 
simultaneous increase of monocyte and macrophage markers like csf1r 
(monocyte/macrophage marker)30, mfap4/mpeg1.1 (early embryonic macrophage marker)31, 32  
were observed from 36 hours post fertilization (hpf) to 5 days post fertilization (dpf) in 
irf2bp2b-defecient mutants compared to controls (Figure 2A-I). The decreased neutrophil 
population was further confirmed by Sudan Black staining (SB)33 at 3dpf in VDA (Figure 2J-J’, 
M), as well as in irf2bp2b-/-//Tg(mpx:eGFP) embryos at 5dpf in CHT (Figure 2K-K’, M). 
Similarly, the expanded macrophage population was shown in irf2bp2b-/-//Tg(mpeg1.1:eGFP) 
embryos at 5dpf (Figure 2L-L’, M). Flow cytometry analysis was performed to quantify the 
numbers of neutrophils and macrophages, and the results showed a 34.9% reduction of eGFP 
positive cells in irf2bp2b-/-//Tg(mpx:eGFP) embryos and a 21.4% increase in 
irf2bp2b-/-//Tg(mpeg1.1:eGFP) embryos (Figure 2N-P). The irf2bp2b-/- zebrafish were not 
only viable but also fertile, which made the myelopoiesis study possible in the adults. 
Morphological staining of the three-month-old adult zebrafish kidney marrow further 
confirmed the expanded macrophages and reduced neutrophils (Figure 3A-C). Meanwhile, 
FACS analyses have also been done with the whole kidney marrows from Tg(mpx:eGFP) and 
irf2bp2b-/-//Tg(mpx:eGFP) lines in three-month-old adults. The myeloid cells population were 
analyzed, and much less neutrophils were found in irf2bp2b-/-//Tg(mpx:eGFP) zebrafish 
compared with controls (29.7% mpx+ vs 84.0% mpx+) (Figure 3D, E). 
 A reverse phenotype emerged once irf2bp2b mRNA was injected in one-cell stage wild 
type embryos (Figure 3F-H). It is worth noting that the overall pan-myeloid marker l-plastin30 
positive cell numbers (which marks both the neutrophils and macrophages), were comparable 
among irf2bp2b-deficient mutants, irf2bp2b overexpressing and wild type embryos (Figure 
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3I-L). In addition, the embryos injected with specific irf2bp2b morpholino (MO) exactly 
phenocopied the aberrant myelopoiesis presented in irf2bp2b knockout embryos (Figure 
S4A-D, I).  
All of the abnormalities in irf2bp2b-deficient and morphant embryos could be effectively 
rescued with the wild type zebrafish irf2bp2b mRNA, confirming the specificity of the 
phenotype (Figure S4E-F, I). Note that zebrafish irf2bp2a mRNA did not rescue the 
myelopoiesis defects, indicating the two paralogs might have distinct roles (data not shown). 
Accordingly, loss of irf2bp2a resulted in a quite different phenotype in zebrafish myelopoiesis, 
which could not be rescued by irf2bp2b mRNA, either (experiments ongoing). Moreover, 
human IRF2BP2b mRNA, but not IRF2BP2a mRNA, could rescue the biased myelopoiesis in 
zebrafish irf2bp2b-defecient mutants, suggesting human IRF2BP2b should be the functional 
ortholog of zebrafish irf2bp2b in this process (Figure S4G-H, I, and data not shown).  
 
Irf2bp2b regulates NMP cell fate choice by repressing pu.1 expression 
The imbalanced proportion of neutrophil and macrophage populations in 
irf2bp2b-defective mutants can result from either abnormalities in apoptosis or proliferation 
rate. To distinguish between these possibilities, TUNEL and antiphosphohistone H3 (pH3) 
antibody staining assays were performed to assess the apoptosis and proliferation status of 
neutrophils and macrophages, respectively. Neither TUNEL nor pH3 assays displayed a 
discernable change in the percentage of double positive stained cells (TUNEL+GFP+, 
pH3+GFP+) within irf2bp2b-/-//Tg(mpx:eGFP) and irf2bp2b-/-//Tg(mpeg1:eGFP) embryos 
compared to controls, indicating that there is no change in either the apoptosis or proliferation 
status of each lineage in irf2bp2b-deficient embryos (Figure S5). Moreover, the fact that 
l-plastin positive cell numbers remained unchanged in both irf2bp2b overexpressing and 
deficient embryos suggested that irf2bp2b might participate in regulating neutrophil versus 
macrophage fate choice.  
The relative level of the master regulators PU.1 and C/EBPα is critical in macrophage 
versus neutrophil cell fate specification6. To ensure a balanced commitment of NMPs, the 
endogenous levels of PU.1 and C/EBPα must be appropriately tuned to a proper range. 
Overexpression of PU.1 can bias myeloid output to macrophage fate, whereas overexpression 
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of C/EBPα exerts a reverse function. Thus either pu.1upregulation or c/ebpα downregulation 
within NMPs could be causative of the biased myelopoiesis toward macrophages in irf2bp2b 
mutants. Firstly we tried to examine the expression levels of pu.1 and c/ebpα by WISH 
analysis. Unfortunately, no obvious difference could be observed between the wild type and 
irf2bp2b-/- embryos. Considering that Pu.1 is expressed in multiple hematopoietic cell lineages 
such as the HSCs, the common lymphoid progenitors, and the common myeloid progenitors34, 
and C/ebpα is also widely expressed in HSCs and myeloid cells35,  the changes of their 
expression levels within NMP might be difficult to be shown. Due to the lack of a lineage cell 
detection cocktail for the zebrafish hematopoietic system, we were unable to isolate the NMP 
subpopulation by flow cytometry to compare the endogenous expression levels of pu.1and 
c/ebpα. Quantitative reverse transcription PCR (RT-qPCR) was performed to detect the 
expression of c/ebpα and pu.1 in wild type and irf2bp2b-defecient whole embryos, and no 
obvious change could be observed (Figure S6), suggesting that the change occurred in NMPs 
might be masked. To resolve this problem, we used a murine myeloid progenitor cell line 
32Dcl3 retrovirally transduced with human IRF2BP2b. RT-qPCR analyses revealed that the 
transcript level of Pu.1 was downregulated, whereas that of C/ebpα was unaffected (Figure 
4A). Meanwhile, expression of multiple monocyte differentiation-related genes such as Mcsfr, 
Mmp1, Tlr2, and Irf8 were reduced, whereas expression of neutrophil differentiation-related 
genes like Gcsfr, Ltf, Prtn3, and Elane were induced (Figure 4A). This observation implies 
that the alteration of pu.1 expression, rather than that of c/ebpα, might account for the balance 
shift of neutrophil and macrophage populations in irf2bp2b-deficient zebrafish embryos. Since 
IRF2BP2 is a negative transcription regulator, we wondered whether pu.1 is a direct target of 
Irf2bp2b, which could be upregulated in irf2bp2b-deficient NMPs. To test this hypothesis, we 
divided the 8.5kb zebrafish pu.1 promoter into four fragments, which were inserted separately 
into a luciferase reporter vector13. The luciferase expression in all of these four constructs was 
inhibited when co-transfected with irf2bp2b in HEK293T cells. The most prominent 
repression was found within the fragment nearest to transcription start site (-1.7kb) (Figure 
4B). Next, a series of in vivo experiments was performed. The 8.5kb pu.1 promoter was cloned 
into a mCherry reporter vector (pu.1:mCherry, Tol2 backbone), which was co-injected with 
Tol2 transposase mRNA into wild type zebrafish embryos with or without irf2bp2b mRNA. 
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Overexpression of irf2bp2b led to a significantly reduced expression of mCherry (Figure 
4C-D). Moreover, pu.1 MO was injected into irf2bp2b-/- embryos, and an effective rescue 
effect of aberrant myelopoiesis was obtained (Figure 4E-J, O). These observations suggested 
that pu.1 expression level might be elevated within NMPs in irf2bp2b mutants. To further 
demonstrate that Irf2bp2b regulates zebrafish NMP cell fate choice through repression of pu.1, 
we took advantage of a zebrafish pu.1G242D mutant line, in which pu.1 transcripts level is 
normal but its protein stability is dramatically decreased13. In pu.1G242D/G242D homozygous 
embryos, biased myelopoiesis toward neutrophils appeared as expected. Note that no obvious 
rescue effect was observed in the irf2bp2b-/-pu.1G242D/G242D double-mutant embryos compared 
to pu.1G242D/G242D embryos, indicating that pu.1 is indeed the downstream of Irf2bp2b in 
determining NMP cell fate (Figure 4K-O).  
 
Irf2bp2b represses pu.1 gene transcription by directly binding to its promoter 
 IRF2BP2 was frequently described as a corepressor14, 16, 17. We then set out to investigate 
how Irf2bp2b represses pu.1 expression. The C-terminal C3HC4-type ring finger motif of 
IRF2BP2 is responsible for mediating the binding with its interacting partners14, 16, 17. The role 
of the N-terminal C4-type zinc finger motif was believed to enable the homo and 
hetero-dimerization/multimerization between different IRF2BP2 family members15. However, 
C4 zinc fingers are typically found in DNA binding domains (DBDs) of transcription factors 
including GATA1-6 as well as nuclear receptors RAR and RXR36, 37. Therefore, the possibility 
that IRF2BP2 functions as a transcription repressor by directly binding DNA should not be 
excluded.  
To characterize how Irf2bp2b represses transcription in NMP cell fate choice, a series of 
point mutations in critical cysteines were introduced into the ring finger (C420/423A, named 
RM thereafter) and the zinc finger motif (C14/17A, named ZM thereafter) of Irf2bp2b as 
previously reported15 (Figure 5A). For the Irf2bp2b RM mutant, interaction with its partners 
was abolished, while the polymerization and the putative DNA binding capacities of the ZM 
mutant were both abrogated. A tetramerization motif from human P53 (amino acids 324-355)  
was fused in frame with the Irf2bp2b ZM mutant (tet-ZM), restoring the polymerization 
capacity of this mutant (Figure 5A). Immunofluorescence analysis (anti-HA antibody) of 
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HEK293T cells transfected with the Irf2bp2b mutants described above demonstrated these 
mutations did not affect nuclear localization as expected (Figure S7) 28.  
The results from in vivo rescue assays revealed that only the RM mutant displayed a 
significant rescue effect similar to wild type irf2bp2b, whilst the ZM and tet-ZM mutants did 
not (Figure 5B-L). These data indicate that direct DNA binding would be indispensable for 
ability of Irf2bp2b to repress pu.1 gene expression in NMP cell fate choice.  
Correspondingly, the luciferase activity assays showed that only wild type Irf2bp2b and 
RM mutant, but not ZM and tet-ZM mutants, exhibited strong repression effects on luciferase 
expression with a -1.7kb zebrafish pu.1 promoter (Figure 6A). This fragment was further 
narrowed down to a short 132bp region (A region) (Figure 6B). To validate that the A region is 
an Irf2bp2b binding site, an in vivo chromatin immunoprecipitation PCR (CHIP-PCR) was 
performed in zebrafish embryos expressing GFP or Irf2bp2b-GFP using an anti-GFP antibody. 
Using the assay, the pu.1 promoter A region was specifically co-immunoprecipitated (co-IP) 
with Irf2bp2b-GFP (Figure 6C).  
Since positively charged amino acids are important to fit into the negatively charged 
phosphate backbone of DNA, several arginines (R10/11/36/55/59) within the C4 zinc finger 
motif were mutated. Luciferase assays showed that only the Irf2bp2bR55/59L double-mutant 
completely lost the ability to repress luciferase expression from the pu.1 promoter (Figure 6D). 
Notably, CHIP-PCR analysis has shown that Irf2bp2bR55/59L mutant could not 
co-immunoprecipitate the pu.1 promoter A region (Figure 6C). As anticipated, this mutant lost 
the rescue effect in irf2bp2b-/- embryos (Figure 6E-J, K). These results indicate that Irf2bp2b 
represses pu.1 gene expression by directly binding to its promoter and R55/R59 are two 
critical amino acids for Irf2bp2b DNA binding. 
Taken together, these findings suggest that Irf2bp2b functions most likely as a 
transcription repressor, rather than a corepressor, in NMPs fate choice during zebrafish 
myelopoiesis.  
 
Repression property of Irf2bp2b is SUMOylation dependent   
IRF2BP2 is a corepressor molecule for its interacting transcription factors14, 17. In the 
current study, we demonstrated that zebrafish Irf2bp2b inhibits pu.1 expression. Thus, we 
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investigated the reason underlying the repression property of IRF2BP2.  
Protein post-translational modification (PTM) plays a pivotal role in regulating function. 
SUMOylation is an important type of PTM which involves a cascade of dedicated enzymes 
that facilitate the covalent modification of specific lysine residues on target proteins with 
monomers or polymers of SUMO (Small Ubiquitin-like Modifier)38. The SUMOylation of 
substrate proteins is frequently linked with transcriptional repression39. Actually, multiple 
adducts (the smallest one was about 10kD larger than the unmodified protein, which was 
nearly the size of one SUMO molecule) of Irf2bp2b were detected by western blot (Figure 7A). 
The SUMO-targeted lysine usually lies in the canonical motif ψKXE40. A SUMO consensus 
motif VKKE (lysine 496) located at the C-terminus of Irf2bp2b was predicted by 
bioinformatics (Figure S1). The putative lysine was mutated to arginine (Irf2bp2bK496R) to 
abolish covalent binding with the SUMO molecule. The modified bands of the Irf2bp2bK496R 
mutant protein disappeared as expected (Figure 7A-B). In addition, an Irf2bp2bE498A mutant 
was constructed to destroy the conservation of the SUMO consensus motif which still 
allowing the accessibility of the lysine 496 to other modifiers. The modified bands 
disappeared as Irf2bp2b K496R mutant did (Figure 7C), indicating Irf2bp2b is a SUMOylated 
substrate.  
In HEK293T cells, GFP-SUMO was cotransfected with HA-tagged wild type Irf2bp2b or 
Irf2bp2bK496R mutant. Immunoprecipitation (IP) assays showed that GFP-SUMO 
co-precipitated with HA-tagged wild type Irf2bp2b, but not with the Irf2bp2bK496R mutant 
(Figure 7D). This further indicated that Irf2bp2b is indeed SUMOylated in cells. 
Luciferase reporter assays with zebrafish pu.1 promoter were then conducted to assess 
Irf2bp2b repression capacity upon its SUMOylation. Results have shown that 
Irf2bp2b-SUMO fusion which mimics fully SUMOylated Irf2bp2b displayed an even stronger 
repression than wild type Irf2bp2b, whereas Irf2bp2bK496R mutant lost the ability to repress 
transcription (Figure 7B, E). Consistently, Irf2bp2b-SUMO and Irf2bp2bK496R mutants 
performed completely different rescue effects in irf2bp2b-defecient mutants (Figure 7F-N).  
Overall, these data supported that Irf2bp2b is a SUMOylated protein in cells and 
SUMOylation is indispensable for its transcription repression property.   
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Irf2bp2b mediates the antagonistic effect of C/ebpα on pu.1 in NMPs cell fate choice  
To ensure balanced commitment of NMPs toward each lineage, the mutual antagonistic 
interplay of the master regulators PU.1 and C/EBPα is very important5, 41. Since Irf2bp2b 
represses pu.1 expression in zebrafish NMPs cell fate choice, we then raised the question 
whether irf2bp2b is a C/ebpα target. 
Two putative C/ebpα binding sites located at -37bp (CS1) and -1595bp (CS2) upstream of 
the transcription start site were predicted in the zebrafish irf2bp2b promoter by bioinformatics 
analysis. A luciferase reporter vector was constructed with the zebrafish irf2bp2b -2.2kb 
promoter and cotransfected with either a c/ebpα expressing vector or an empty vector. 
Luciferase expression was significantly enhanced by C/ebpα (Figure 8A). Similar expression 
enhancement was also obtained when an mCherry expressing vector carrying the same 
irf2bp2b promoter (irf2bp2b:mCherry, in Tol2 backbone) was co-injected with c/ebpα and 
Tol2 transposase mRNAs into zebrafish embryos (Figure 8B-C). This enhancement was 
completely abolished when the predicted C/ebpα binding sites were deleted in the irf2bp2b 
promoter (Figure 8D).  
Finally, c/ebpα mRNA was injected into irf2bp2b-/- knockout and wild type embryos, 
respectively. The overexpression of c/ebpα mRNA induced biased myelopoiesis toward 
neutrophils in control embryos (Figure 8E-F, I-J, M), but had no effect on myelopoiesis in 
irf2bp2b-/- embryos (Figure 8G-H, K-M).  
Meanwhile, to elucidate whether gfi1 could also be a secondary determinant of C/ebpα, 
gfi1 mRNA was injected into wild type embryos. Although gfi1 overexpression did give rise to 
a remarkable expansion of the neutrophil population, the macrophage population was 
unaffected (data not shown). Moreover, such overexpression did not display any rescue effect 
in irf2bp2b-deficient embryos (Figure S8E-F, I).  
In summary, these data indicate that Irf2bp2b plays a pivotal role in mediating the 
antagonistic function of C/ebpα on pu.1 transcription regulation, which fine tunes the pu.1 
expression level in NMPs and determines NMPs cell fate choice in order to maintain a normal 
neutrophil and macrophage population ratio (Figure 8N).  
 
Discussion  
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Although multiple regulators involved in hematopoietic lineage restriction have been 
characterized, the molecular details of NMP differentiation are still under debate. The 
relationship between the master regulators PU.1 and C/EBPα in myelopoiesis is complicated, 
which is not only synergistic, but also antagonistic41. On one side, C/EBPα can stimulate PU.1 
expression by directly binding to its promoter42, 43. On the other side, C/EBPα can directly 
interact with PU.1 and block its function, or inhibit PU.1 indirectly through activation of the 
transcription repressor GFI144, 45, which in turn inhibits PU.1 activity through protein-protein 
interaction46. In the present study, we determined that in the balance between granulocytic and 
macrophagic commitment, zebrafish irf2bp2b acts as a direct target of C/ebpα to repress pu.1 
expression. Our data also suggest that during definitive myelopoiesis stage of zebrafish, it is 
the C/ebpα-Irf2bp2b-Pu.1 axis, not C/ebpα-Gfi1-Pu.1, that regulates NMP cell fate choice. 
Thus zebrafish Irf2bp2b acts as a novel player in NMP cell fate decision and adds a new layer 
of complexity to this fine-tuning process. 
Note that in irf2bp2b-defecient embryos the primitive macrophages and neutrophils 
developed normally (Figure S3C-D, G-H, K-L). Previously it has been reported that a 
Pu.1-Runx1 negative feedback loop determines the RBI-originated macrophage versus 
neutrophil fate13. Runx1 was shown to directly inhibit the pu.1 promoter in the study, however, 
injection of runx1 mRNA into our irf2bp2b-defecient embryos could not rescue the aberrant 
myelopoiesis (Figure S8G-I). To further elucidate whether irf2bp2b regulates primitive 
myeloid differentiation, we first determined irf2bp2b is present in primitive versus definitive 
progenitor cells (Figure S9A). Then we injected irf2bp2b mRNA into one-cell stage wild type 
embryos. The biased myelopoiesis could only be observed in VDA at 48hpf (Fig 3F-H). By 
contrast, c/ebp1, lyz, and mfap4 were all normally expressed in RBI at 22hpf (Fig S9B-H). 
Based on these observations, we believe that even though irf2bp2b is expressed in both 
primitive and definitive myeloid progenitor cells, distinct regulatory mechanisms are 
implicated in cell fate determination of NMPs derived from VDA/CHT and RBI. 
The DNA binding properties of IRF2BP2 has never been studied. Although C4-type zinc 
fingers are found in Irf2bp2, GATA, RARα, and RXR, there are still some differences. While a 
single C-X2-C-X17-C-X2-C type zinc finger exists in Irf2bp2, two consecutive ones are 
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contained in GATA. RARα and RXR have two C-X2-C-X13-C-X2-C type zinc fingers. GATA 
binds specifically to consensus sequence47. Physiologically RAR-RXR heterodimer binds to 
responsive elements that consist of two AGGTCA core motifs48. To find out the binding site of 
Irf2bp2b within the pu.1 promoter, we first wondered whether it was similar to that of GATA 
or RAR/RXR. Two putative GATA binding sites (GS1, GS2) were predicted within the 132bp 
A region, whereas no RAR/RXR binding sites could be found. However, both GATA site 
deletion constructs could still be inhibited by Irf2bp2b (Figure S10). Therefore, Irf2bp2b 
presumably has its own binding site.  
The majority of APL patients bear a PML-RARα fusion gene. However, in APL variants 
RARα is fused with genes other than PML. Recently, four APL cases with a novel fusion, 
IRF2BP2-RARα, were identified20-23. All X-RARα fusion related APL is characterized by the 
blockage at the promyelocyte stage and the inhibition of a large set of differentiation related 
genes targeted by corepressors recruited onto RARα moiety49. Note that the zinc finger motif 
of IRF2BP2 is intact in all of the four patients carrying the IRF2BP2-RARα oncoprotein20-23, 
thus two potential DBDs from each moiety are retained simultaneously in the fusion. Such a 
phenomenon is very rare in a chimeric fusion protein composed of two transcription factors. 
This raises a few questions about IRF2BP2-RARα related APL. Since dimerization is one of a 
prerequisite for all X-RARα fusions50, does the IRF2BP2 moiety serves merely as an interface 
for dimerization of IRF2BP2-RARα, or does IRF2BP2 have other contributions, such as DNA 
binding, in APL pathogenesis? Does IRF2BP2-RARα arise at NMP level? If it is expressed in 
NMPs, whether IRF2BP2-RARα could trigger the biased NMPs cell fate choice favoring 
granulopoiesis? Further studies are needed to answer these questions.   
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Figure legends  
Figure 1. The establishment of a zebrafish irf2bp2b knock out line. (A) Schematic 
representation of Cas9 target site in the first exon of zebrafish irf2bp2b. The deleted 
nucleotides in the mutant gene are marked by hyphens. (B) Schematic representation of wild 
type (501 amino acids) and mutant Irf2bp2b proteins (201 amino acids). The site where the 
frameshift was introduced is marked by triangles. (C) Western blot analysis of HA-tagged wild 
type and mutant Irf2bp2b proteins. (D) Immunofluorescence analysis of wild type (top panel) 
and mutant Irf2bp2b (bottom panel) proteins, demonstrating that the truncated protein lost its 
nuclear localization. 
 
Figure 2. Deficiency of irf2bp2b leads to an expanded macrophage population at the 
expense of the neutrophil population during definitive myelopoiesis. (A-D’) WISH 
analyses of neutrophil markers c/ebp1 (A, A’), mpx (B-C’), and lyz (D, D’) at 36hpf, 48hpf, 
and 5dpf in wild type (WT) and irf2bp2b-deficient embryos, respectively. Grey boxes and red 
arrows indicate the main position of positive cells for each marker. n/n, number of embryos 
showing representative phenotype/total number of embryos examined. (E-H’) WISH analyses 
of monocytes/macrophages markers csf1r (E, E’), mpeg1.1 (F, F’), and mfap4 (G-H’) at 48hpf 
and 5dpf. (I) Statistical results for A-H’. Error bars represent ± SD of at least 15-30 embryos. p 
values are denoted by asterisks; (***)P<0.001 (Student’s t test). (J, J’) Sudan Black positive 
cells are reduced in irf2bp2b-deficient embryos at 3dpf. (K, K’) GFP positive cells are 
decreased in irf2bp2b-/-//Tg(mpx:eGFP) embryos at 5dpf. (L, L’) GFP positive cells increased 
in irf2bp2b-/-//Tg(mpeg1.1:eGFP) embryos at 5dpf. (M) Statistical results for J-L’. 
(***)P<0.001; (****)P<0.0001 (Student’s t test). (N, O) FACS Analysis of eGFP positive 
cells in wild type and irf2bp2b-/-//Tg(mpx:eGFP) or irf2bp2b-/-//Tg(mpeg1.1:eGFP) embryos at 
2dpf. (P) Statistical results for N, O. Error bars represent ± SD of 3 replicates. (**) P<0.01; 
(***) P<0.001 (Student’s t test).  
 
Figure 3. Biased myelopoiesis in irf2bp2b-deficient adult zebrafish. (A, B) HE staining 
morphological analysis of the kidney marrow collected from the three-month-old adult wild 
type (one male and one female) and irf2bp2b-/- (two males and one female) zebrafish. One 
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representative image of each group was shown. Green and red arrows indicated the typical 
neutrophils and macropahges, respectively. (C) Statistical results for A, B. Error bars represent 
± SD of at least 15 images. (***) P<0.001 (Student’s t test). (D) FACS analysis of whole 
kidney marrows from Tg(mpx:eGFP) and irf2bp2b-/-//Tg(mpx:eGFP) lines in three-month-old 
adults. The myeloid cells within R5 gate were analyzed with fluorescence. (E) Statistical 
results for D. Error bars represent ± SD of 3 replicates. (****) P<0.0001 (Student’s t test). 
(F-G’) Mpx and mfap4 were used to monitor neutrophils and macrophages development in 
wild type and irf2bp2b mRNA injected embryos by WISH. (I-K) WISH analyses of 
pan-myeloid marker l-plastin of wild type, irf2bp2b-/-, and irf2bp2b mRNA injected embryos. 
(H, L) Statistical results for F-G’, I-K. Error bars represent ± SD of at least 15-30 embryos. p 
values are denoted by asterisks; (ns): no statistical significance; (**) P<0.01; (***) P<0.001 
(Student’s t test). 
 
Figure 4. Irf2bp2b dictates NMP cell fate through inhibition of pu.1expression. (A) 
RT-qPCR analysis of neutrophil and macrophage development related genes in 32Dcl3 cells 
constitutively expressing human IRF2BP2b. Error bars represent ± SD of at least 3 replicates. 
p values are denoted by asterisks; (ns): no statistical significance; (**)P<0.01; (***)P<0.001 
(Student’s t test). (B) Schematic diagram of the -8.5kb zebrafish pu.1 promoter dual luciferase 
report vector (top panel). Dual Luciferase vectors each with a fragment of the zebrafish pu.1 
promoter as indicated were cotransfected into HEK293T cells with an irf2bp2b expressing 
vector or empty vector pCS2+. Luciferase activity with irf2bp2b expression was detected and 
normalized to empty vector pCS2+ which was set to 1.0 (bottom panel). Error bars represent ± 
SD of at least 3 replicates. p values are denoted by asterisks; (***)P<0.001; (****)P<0.0001 
(Student’s t test). (C, D) Representative fluorescent images of transient mCherry expression at 
48hpf of WT and irf2bp2b overexpressing embryos injected with a -8.5kb pu.1:mCherry 
construct. (E-N) WISH assay of mpx and mfap4 in WT (E, F), irf2bp2b-/- mutant embryos (G, 
H), irf2bp2b-/- mutant embryos injected with pu.1 MO (I, J), pu.1G242D/G242D mutants (K, L), 
and irf2bp2b-/-pu.1 G242D/G242D double-mutant embryos (M, N). (O) Statistic result for E-N. 
Error bars represent ± s.e.m of 15-30 embryos. p values are denoted by asterisks; (**)P<0.01; 
(***)P<0.001 (ANOVA followed by LSD post hoc test for multiple comparisons). 
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Figure 5. DNA binding property is indispensable for Irf2bp2b in regulating NMP cell 
fate choice. (A-L) Irf2bp2b mRNA rescue assays in irf2bp2b-/- embryos. (A) Structure of 
variant forms of Irf2bp2b, including WT, ZM, tet-ZM, and RM mutant. (B-L) Mpx and mfap4 
probes were used in WISH to examine rescue effect with irf2bp2b ZM (F, G), tet-ZM (H, I), 
and RM mutant mRNA injections (J, K). (L) Error bars represent ± s.e.m of 15-30 embryos. p 
values are denoted by asterisks; (ns): no statistical significance; (**)P<0.01; 
(***)P<0.001(ANOVA followed by LSD post hoc test for multiple comparisons).  
 
Figure 6. DNA binding property is indispensable for Irf2bp2b in regulating NMP cell 
fate choice (continued). (A) Ability of Irf2bp2b mutants to repress the zebrafish pu.1 
promoter (-1.7kb). Error bars represent ± s.e.m of at least 3 replicates. p values are denoted by 
asterisks; (***)P<0.001 (ANOVA followed by LSD post hoc test for multiple comparisons). 
(B) Irf2bp2b represses luciferase expression from the pu.1 promoter 132bp A region (from 
-1308bp to -1439bp). Error bars represent ± SD of at least 3 replicates. p values are denoted by 
asterisks; (***)P<0.001 (Student’s t test). (C) CHIP-PCR analysis of pu.1 promoter A region 
in zebrafish embryos expressing GFP, Irf2bp2b-GFP or Irf2bp2bR55/59L-GFP using an anti-GFP 
antibody. The position of the primers used to amplify the pu.1 promoter A region are indicated 
with red arrows. Error bars represent ± s.e.m of at least 3 replicates. p values are denoted by 
asterisks; (****)P<0.0001 (ANOVA followed by LSD post hoc test for multiple comparisons). 
(D) Luciferase repression assays of Irf2bp2b mutants on zebrafish pu.1 promoter (-1.7kb). 
Error bars represent ± s.e.m of at least 3 replicates. p values are denoted by asterisks; 
(***)P<0.001 (ANOVA followed by LSD post hoc test for multiple comparisons). (E-J) 
Irf2bp2bR55/59L mRNA rescue assays in irf2bp2b-/- mutant embryos. Mpx and mfap4 probes 
were used in WISH to examine rescue effects associated with Irf2bp2bR55/59L mutant mRNA 
injection. (K) Error bars represent ± s.e.m of at least 3 replicates. p values are denoted by 
asterisks; (***)P<0.001 (ANOVA followed by LSD post hoc test for multiple comparisons). 
 
Figure 7. SUMOylation is indispensable for transcription repression of Irf2bp2b. (A) 
Western blot analysis (anti-HA) of HA-tagged WT and Irf2bp2bK496R mutant proteins 
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expressed in HEK293T cells. (B) Structure of variant forms of Irf2bp2b, including WT, 
Irf2bp2bK496R, and Irf2bp2b-SUMO mutant. (C) Western blot analysis (anti-HA) of 
HA-tagged WT, Irf2bp2bK496R and Irf2bp2bE498A mutant proteins expressed in HEK293T cells. 
(D) HA tagged WT or Irf2bp2bK496R mutant protein was immunoprecipitated (IP) with an 
anti-HA antibody from HEK293T cells co-expressing GFP-SUMO, and SUMOylated 
Irf2bp2b protein was detected by western blot with an anti-GFP antibody. (E) Repression of 
luciferase expression from the zebrafish pu.1 promoter (-1.7kb) by Irf2bp2b mutants. Error 
bars represent ± s.e.m of at least 3 replicates. p values are denoted by asterisks; (***)P<0.001 
(ANOVA followed by LSD post hoc test for multiple comparisons). (F-M) Irf2bp2b-SUMO 
and irf2bp2bK496R rescue assays in irf2bp2b-/- mutant embryos. Mpx and mfap4 probes were 
used in WISH to examine rescue effects performed with irf2bp2bK496R mutant (J, K), and 
irf2bp2b-sumo (L, M) mRNA injections. (N) Error bars represent ± s.e.m of 15-30 embryos. p 
values are denoted by asterisks; (ns): no statistical significance; (**)P<0.01; (***)P<0.001 
(ANOVA followed by LSD post hoc test for multiple comparisons). 
 
Figure 8. Irf2bp2b mediates the antagonistic effect of C/ebpα on pu.1. (A) Schematic 
diagram of zebrafish irf2bp2b promoter (-2.2kb) (top panel). C/ebpα activation on irf2bp2b 
promoter was measured by luciferase activity assay (bottom panel). Error bars represent ± SD 
of at least 3 replicates. p values are denoted by asterisks; (****)P<0.0001 (Student’s t test). (B, 
C) Representative fluorescent images of transient mCherry expression at 20hpf of WT and 
c/ebpα overexpressing embryos injected with an irf2bp2b:mCherry construct, respectively 
(bottom panel). Corresponding bright field images (top panel). (D) Schematic diagram of 
zebrafish irf2bp2b promoter (-2.2kb), in which two putative C/ebpα binding sites are predicted 
(CS1, CS2) (top panel). Luciferase activity assays of C/ebpα activation on the irf2bp2b CS1 
and CS2 mutant promoters (bottom panel). Data shown are the means ± SD of at least three 
independent experiments. Error bars represent ± SD of at least 3 replicates. p values are 
denoted by asterisks; (***)P<0.001 (Student’s t test). (E-L) C/ebpα mRNA overexpression in 
WT and irf2bp2b-/- mutant embryos. Mpx and mfap4 probes were used in WISH to examine 
rescue effect. (M) Statistical results for E-L.  
Error bars represent ± s.e.m of 15-30 embryos. p values are denoted by asterisks; (ns): no 
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statistical significance; (*)P<0.1; (**)P<0.01; (***)P<0.001 (ANOVA followed by LSD post 
hoc test for multiple comparisons). (N) Schematic depiction of neutrophil and macrophage 
fate regulation in WT (left panel) and irf2bp2b-/- (right panel) zebrafish.  
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Supplemental Figure 1. Alignment of protein sequences of IRF2BP2 family members. 
Alignment of zebrafish (Dr) Irf2bp2a and Irf2bp2b, human (Hs) IRF2BP2a and IRF2BP2b 
protein sequences. Functional domains including the C4-type zinc finger and the 
C3HC4-type ring finger are boxed, and the critical cysteine (C) and histidine (H) residues are 
denoted by asterisks. The conserved nuclear localization signal (NLS) in the intermediate 
domain is also boxed. The extra 16 amino acids of the human IRF2BP2a isoform compared 
to IRF2BP2b are underlined. The consensus SUMOylation site VKKE located at the 
C-terminus is double underlined. 
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Supplemental Figure 2. Expression of irf2bp2b transcript in erythroid and myeloid cells. 
Irf2bp2b transcript was detected by RT-qPCR analysis in the GFP positive cells enriched 
from Tg(gata1:eGFP), Tg(pu.1:eGFP), Tg(mpx:eGFP), and Tg(mpeg1.1:eGFP) embryos at 
48hpf, respectively. β-actin served as internal control. 
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Supplemental Figure 3. Expression of lineage specific markers during primitive and 
definitive hematopoiesis stages in irf2bp2b-deficient embryos. (A-L) WISH analyses of 
scl (A, B) at 20hpf, and c/ebp1 (C, D), gata1 (E, F), lyz (G, H) mpx (I, J), mfap4 (K, L) at 
22hpf. (M, N) WISH analyses of runx1 at 36hpf, (O-R) WISH analyses of c-myb at 36hpf 
and 5dpf, WISH analyses of hbαe1 (S, T), and rag1 (U, V) at 5dpf, respectively. (W, X) 
Statistical results for A-L, M-R. Error bars represent ± SD of at least 15-30 embryos. p 
values are denoted by asterisks; (ns): no statistical significance.  
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Supplemental Figure 4. Deficiency of irf2bp2b leads to an expanded macrophage 
population at the expense of the neutrophil population during definitive myelopoiesis. 
(A-D) WISH analyses of mpx and mfap4 in wild type embryos injected with irf2bp2b gene 
specific MO. (E-H) Zebrafish irf2bp2b and human IRF2BP2b mRNA rescue aberrant 
myelopoiesis phenotype in irf2bp2b-/- mutant embryos. (I) Statistical results for A-H. Error 
bars represent ± s.e.m of at least 15-30 embryos. p values are denoted by asterisks; (**) 
P<0.01; (***) P<0.001 (ANOVA followed by LSD post hoc test).  
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Supplemental Figure 5: Apoptosis and proliferation of neutrophil and macrophage 
lineages are normal. (A-C’) Double immunostaining of GFP and TUNEL in CHT at 48hpf 
of Tg(mpx: eGFP) and irf2bp2b-/-//Tg(mpx:eGFP) mutant embryos. (D) Statistic result for 
C-C’. Error bars represent ± SD of 15-30 embryos. (ns): no statistical significance. (E-G’) 
Double immunostaining of GFP and TUNEL in CHT at 48hpf of Tg(mpeg1.1:eGFP) and 
irf2bp2b-/-//Tg(mpeg1.1:eGFP) mutant embryos. (H) Statistic result for G-G’. Error bars 
represent ± SD of 15-30 embryos. (I-K’) Double immunostaining of GFP and pH3 in CHT at 
48hpf of Tg(mpx:eGFP) and irf2bp2b-/-//Tg(mpx:eGFP) mutant embryos. (L) Statistic result 
for K-K’. Error bars represent ± SD of 15-30 embryos. (M-O’) Double immunostaining of 
GFP and pH3 in CHT at 48hpf of Tg(mpeg1.1:eGFP) and irf2bp2b-/-//Tg(mpeg1.1:eGFP) 
mutant embryos. (P) Error bars represent ± SD of 15-30 embryos.  
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Supplemental Figure 6. The change of c/ebpα and pu.1 in NMPs might be masked. 
RT-qPCR analysis of c/ebpα and pu.1 in wild type and irf2bp2b-defecient whole embryos at 
22hpf (A) and 48hpf (B). β-actin was used as internal control. 
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Supplemental Figure 7: Immunofluorescence analysis of HA-tagged wild type and 
mutant Irf2bp2b proteins. RM, ZM, tet-ZM, Irf2bp2bR10/11L, Irf2bp2bR36L, Irf2bp2bR55/59L, 
and Irf2bp2bK496R maintain the nuclear localization. 
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Supplemental Figure 8: Runx1 and gfi1aa overexpressions in irf2bp2b-defecient 
embryos. (A-H) Mpx and mfap4 were probed to monitor neutrophil and macrophage 
development. (I) Statistical results for A-H. Error bars represent ± s.e.m of at least 15-30 
embryos. p values are denoted by asterisks; (**) P<0.01; (***) P<0.001 (ANOVA followed 
by LSD post hoc test). 
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Supplemental Figure 9: Irf2bp2b does not play a role in RBI-originated macrophage 
versus neutrophil fate choice. (A) The GFP positive cells were isolated from Tg(pu.1:eGFP) 
embryos at 22hpf (primitive hematopoiesis stage) and 5dpf (definitive hematopoiesis stage), 
respectively. RT-qPCR analysis (β-actin was used as internal control) showed that irf2bp2b 
transcript was detected at both time points, suggesting that irf2bp2b is expressed in both 
primitive and definitive progenitor cells. (B-G) Overexpression of irf2bp2b mRNA could not 
impair RBI-originated myelopoiesis. (H) Statistical results for B-G. Error bars represent ± 
SD of at least 15-30 embryos. p values are denoted by asterisks; Error bars represent ± SD of 
3 replicates. (ns): no statistical significance; (**) P<0.01; (***) P<0.001 (Student’s t test).  
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Supplemental Figure 10: Luciferase results of Irf2bp2b repression on wild type 
zebrafish pu.1 promoter A region, and GS1, GS2 mutant constructs. Error bars represent 
± SD of at least 3 replications. p values are denoted by asterisks; (**)P<0.01; (****)P<0.001 
(Student’s t test).  
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Supplementary Methods 
Generation of irf2bp2b knockout line 
For crisp9 mediated irf2bp2b knockout zebrafish generation, guide RNA (gRNA) targeting 
exon1 of irf2bp2b was designed using an online tool ZiFiT Targeter software 
(http://zifit.partners.org/ZiFiT), which was synthesized by cloning the annealed 
oligonucleotides into the sgRNA expression vector as previously described(1). The target site 
was 5’- GGAATGGCTCCGGTCCGACG-3’. The injected F0 founder embryos were raised 
to adulthood and then outcrossed with wild type zebrafish. F1 embryos carrying potential 
indel mutations were raised to adulthood. Then PCR amplification and sequencing were 
carried on genomic DNA isolated from tail clips of F1 fish to identify mutants. 
 
Plasmid construction 
Zebrafish irf2bp2b was cloned into PCS2+ vector. The zebrafish irf2bp2b serial mutants were 
generated with the indicated primers (Table1). As for the luciferase reporter, the -8.5kb 
upstream frame of zebrafish pu.1 was devided into four fragments and then inserted into 
PGL3 promoter vector (Promega) respectively. The zebrafish irf2bp2b gene -2.2kb upstream 
sequence was cloned into PGL3 basic vector (Promega). Primers used were listed in Table1. 
 
In vitro synthesis of antisense RNA probe 
Antisense RNA probes were prepared by in vitro transcription according to the standard 
protocol. The following digoxigenin-labeled antisense probes were used: c/ebp1, mpx, lyz, 
mfap4, csf1r, mpeg1.1, l-plastin. 
 
Whole-mount in situ hybridization (WISH) 
Digoxigenin (DIG)-labeled RNA probes were transcribed with T7, T3 or SP6 polymerase 
(Ambion, Life Technologies, Carlsbad, CA, USA). Whole-mount mRNA in situ 
hybridization was performed as described previously(2). The probes labeled by DIG (Roche, 
Basel, Switzerland) were detected using alkaline phosphatase-coupled anti-digoxigenin Fab 
fragment antibody (Roche, Basel, Switzerland) with BCIP/NBT staining (Vector 
Laboratories, Burlingame, CA, USA). 
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MO and mRNA injection 
The MO and mRNA were injected at the one-cell stage of the embryos. The MOs were 
designed and generated by Gene Tools, Philomath, OR, USA. MO sequences were shown in 
Table 2. Full-length capped mRNA samples were all synthesized from linearized plasmids by 
using the mMessagemMachine SP6 kit (Life Technologies-Ambion, Austin, TX, USA). 
 
Sudan Black staining 
The embryos treated with 4% paraformaldehyde (PFA) overnight at 4℃ were incubated with 
a Sudan Black (Sigma-Aldrich) solution for about 30 minutes to detect the granules of 
granulocytes. The detailed method was described previously(3). Staining was then observed 
under a microscope. 
 
Cell collection and FACS analysis  
Cell collection and FACS analysis were performed essentially as described(4). Wild type 
Tg(mpx:eGFP) and irf2bp2b-/-//Tg(mpx:eGFP) embryos, as well as wild type 
Tg(mpeg1.1:eGFP) and irf2bp2b-/-//Tg(mpeg1.1:eGFP) embryos were dissociated into single 
cells using 0.05% trypsin (Sigma) as previously described(5) at 48hfp. These dissociated 
cells were passed through a 40-µm mesh, centrifuged at 450g, and suspended in 5% 
FBS/PBS before addition of propidium iodide to a final concentration of 1 µg/ml for 
exclusion of dead cells. FACS analysis was based on forward and side scatter characteristics, 
propidium iodide exclusion and GFP fluorescence using a FACS Vantage flow cytometer 
(Beckton Dickenson). Wild type embryos (without GFP) were used as blank to determine the 
background values in GPF-controls. 
 
H&E staining of paraffin sections 
After being collected and fixed with 4% paraformaldehyde (PFA) overnight at 4 °C, the 
embryos were dehydrated by progressively higher concentrations of ethanol, substituted with 
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xylene, embedded in paraffin wax, cut into 3-5µm slices, for hematoxylin and eosin (H&E) 
staining. Then the samples were imaged under a light microscope (Nikon). 
 
PH3 staining and TUNEL assay 
Tg(mpx:eGFP) , Tg(mpeg1.1:eGFP), irf2bp2b-/-//Tg(mpx:eGFP), and 
irf2bp2b-/-//Tg(mpx:eGFP) embryos were collected at 48hpf and fixed in 4% 
paraformaldehyde. The fixed embryos were incubated with primary rabbit 
anti-phospho-histoneH3 (pH3; Upstate Biotechnology) and goat anti-GFP (Abcam) 
antibodies according to the manufacturer’s protocol and subsequently stained with 
AlexaFluor-647 anti–rabbit and AlexaFluor-488 anti–goat secondary antibodies (Invitrogen). 
TUNEL assays were performed using the In Situ Cell Death Detection Kit and TMR Red 
(Roche Diagnostics) according to the manufacturer’s recommendations. Images were taken 
using Olympus FV 1000 confocal microscopy equipped with the FV10-ASW version 3 
software. 
 
Retroviral transduction 
The IRF2BP2 cDNA was inserted into pMSCV-neo vector. For retroviral transduction, plat-E 
cells were transiently transfected with retroviral vectors. 32Dcl3 Cells were transduced by 
spinoculation (1,300 g, 30℃, 90 min) in a retroviral supernatant supplemented with 
cytokines and 4µg/ml polybrene (Sigma). Transduced cells were selected by G418 treatment 
(800mg/ml, Sigma). 
 
Quantitative RT-PCR   
The quantitativePCR was carried out with SYBR Green Real-time PCR Master Mix 
(TOYOBO) with ABI 7900HT real-time PCR machine, and analyzed with Prism software. 
The primers used were listed in Table. 
 
ChIP-PCR 
For ChIP analysis, GFP or GFP-Irf2bp2b expressing embryos were harvested at 48hpf for 
brief fixation. Cross-linked chromatin was immunoprecipitated with anti-GFP antibody 
14	
	
	
according to the procedure described(6). The resultant immunoprecipitated samples were 
subjected to semiquantitative PCR using primer pairs (Table1). 
 
Cell culture and Luciferase reporter assay. 
HEK293T cells were maintained in DMEM (Life technologies, Grand Island, NY, USA) 
with 10% Fetal Bovine Serum (Life technologies, Grand Island, NY, USA). Plasmid 
transfection was carried out with Effectene Transfection Reagent (QIAGEN) according to 
manufacturer’s instruction. For the luciferase reporter assay, cells were harvested 48 hours 
after transfection and were analyzed using the Dual Luciferase Reporter Assay Kit (Promega, 
Maddison, WI, USA), according to the manufacturer’s protocols. 
 
Western blot and Co-Immunoprecipitation assay 
HEK293T cells, which had been transfected with plasmids for 48h, were washed with 
phosphate-buffered saline (PBS) buffer for 1 minute 3 times. Lysates were prepared using 
RIPA lysis buffer (Beyotime, Shanghai, China) with proteinase inhibitor (Roche, Basel, 
Switzerland), after shaking on ice for 30 minutes, the cells were harvested and centrifuged at 
15,000 ×  g for 30 min. Rabbit anti-HA antibody (Santa Cruz) was mixed with the 
protein-G-agarose beads (30 µl) in the supernatant at 4 °C overnight. The beads were 
prepared by centrifugation and washed three times with RIPA lysis buffer. Proteins binding 
to the beads were eluted by adding 30 µl of 2× SDS sample buffer and analyzed by 
immunoblotting using anti-GFP antibody (Santa Cruz).  
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